Blood Pressure Effects on Retinal Vessel Diameter and Flicker Response: A 1.5-Year Follow-Up

2006 ◽  
Vol 16 (4) ◽  
pp. 560-565 ◽  
Author(s):  
E. Nagel ◽  
W. Vilser ◽  
A. Fink ◽  
T. Riemer ◽  
I. Lanzl
Author(s):  
Katherine Banks ◽  
Mabel Kyinn ◽  
Shalem Y. Leemaqz ◽  
Eleanor Sarkodie ◽  
Deborah Goldstein ◽  
...  

Gender-diverse people likely suffer from higher rates of cardiovascular disease than cisgender people. Studies on the effects of gender-affirming hormone therapy (GAHT) on blood pressure in adult transgender populations have been inconsistent. We sought to address knowledge gaps on this topic by conducting the largest and longest observational study to date using multiple blood pressure readings from a racially and ethnically diverse sample. We followed the blood pressure of 470 transgender and gender-diverse adult patients (247 transfeminine and 223 transmasculine; mean age, 27.8 years) seen at a Federally Qualified Health Center and an academic endocrinology practice, both in Washington DC. Blood pressure was measured at baseline and at multiple follow-up clinical visits up to 57 months after the initiation of GAHT. Our study found that within 2 to 4 months of starting GAHT, mean systolic blood pressure was lower in the trans feminine group by 4.0 mm Hg ( P <0.0001) and higher in the trans masculine group by 2.6 mm Hg ( P =0.02). These blood pressure changes were maintained during the whole follow-up period. There were no changes to diastolic blood pressure for either group. The prevalence of stage 2 hypertension decreased in the trans feminine group by 47% ( P =0.001) within 2 to 4 months of GAHT. In conclusion, our data support routine blood pressure monitoring after the initiation of GAHT. Further research is needed on the effects of GAHT in older gender-diverse individuals and on optimal formulations of GAHT.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Jill Korsiak ◽  
Kay-Lynne Perepeluk ◽  
Nicholas G. Peterson ◽  
Ryan Kulka ◽  
Scott Weichenthal

AbstractLittle is known about the early-life cardiovascular health impacts of fine particulate air pollution (PM2.5) and oxidant gases. A repeated-measures panel study was used to evaluate associations between outdoor PM2.5 and the combined oxidant capacity of O3 and NO2 (using a redox-weighted average, Ox) and retinal vessel diameter and blood pressure in children living in a region impacted by residential biomass burning. A median of 6 retinal vessel and blood pressure measurements were collected from 64 children (ages 4–12 years), for a total of 344 retinal measurements and 432 blood pressure measurements. Linear mixed-effect models were used to estimate associations between PM2.5 or Ox (same-day, 3-day, 7-day, and 21-day means) and retinal vessel diameter and blood pressure. Interactions between PM2.5 and Ox were also examined. Ox was inversely associated with retinal arteriolar diameter; the strongest association was observed for 7-day mean exposures, where each 10 ppb increase in Ox was associated with a 2.63 μm (95% CI − 4.63, − 0.63) decrease in arteriolar diameter. Moreover, Ox modified associations between PM2.5 and arteriolar diameter, with weak inverse associations observed between PM2.5 and arteriolar diameter only at higher concentrations of Ox. Our results suggest that outdoor air pollution impacts the retinal microvasculature of children and interactions between PM2.5 and Ox may play an important role in determining the magnitude and direction of these associations.


Diabetes ◽  
1994 ◽  
Vol 43 (12) ◽  
pp. 1445-1449 ◽  
Author(s):  
A. D. Morris ◽  
J. R. Petrie ◽  
S. Ueda ◽  
J. M. Connell ◽  
H. L. Elliott ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document